Cluster of erythromycin- and ciprofloxacin-resistant Campylobacter jejuni subsp jejuni from 1999 to 2001 in men who have sex with men, Quebec, Canada

被引:31
作者
Gaudreau, C
Michaud, S
机构
[1] CHUM, Hop St Luc, Dept Microbiol Med & Infectiol, Montreal, PQ H2X 3J4, Canada
[2] Ctr Hosp Univ Sherbrooke, Dept Microbiol Med & Infectiol, Sherbrooke, PQ, Canada
关键词
D O I
10.1086/375221
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
From December 1999 to November 2001, a cluster of multi-drug-resistant Campylobacter jejuni subsp. jejuni enterocolitis was suspected within the male population of Montreal. Nine men, aged 26-40 years, presented with an erythromycin- and ciprofloxacin-resistant, tetracycline-susceptible C. jejuni enterocolitis. In March 1998 and February 2000, 2 additional men, aged 23 and 27 years, were infected with an erythromycin-resistant, ciprofloxacin and tetracycline-susceptible C. jejuni. All isolates were identical according to pulsed-field gel electrophoresis and flagellin typing. Epidemiological data suggested a sexually transmitted enteric infection; all patients infected with the locally acquired epidemic strain were men, the 8 patients for whom sexual orientation data were available identified themselves as men who have sex with men (MSM), and 3 of the patients had had a sexually transmitted Shigella sonnei infection during a proven outbreak among MSM. Eight patients, 6 of whom were identified as MSM, resided in a predominantly homosexual district of Montreal or its surrounding neighborhoods. The emergence of multidrug-resistant C. jejuni justifies routine susceptibility-testing of these bacteria. MSM should be educated about the prevention of sexually transmitted enteric pathogens.
引用
收藏
页码:131 / 136
页数:6
相关论文
共 21 条
[1]  
[Anonymous], [No title captured]
[2]  
BLASER MJ, 2000, PRINCIPLES PRACTICE, P2276
[3]  
Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P922
[4]   Quinolone and macrolide resistance in Campylobacter jejuni and C-coli:: Resistance mechanisms and trends in human isolates [J].
Engberg, J ;
Aarestrup, FM ;
Taylor, DE ;
Gerner-Smidt, P ;
Nachamkin, I .
EMERGING INFECTIOUS DISEASES, 2001, 7 (01) :24-34
[5]   Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli [J].
Gaudreau, C ;
Gilbert, H .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (06) :707-712
[6]   Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada [J].
Gaudreau, C ;
Gilbert, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :2106-2108
[7]  
GAUDREAU C, 2002, AMMIQALE, V10, P35
[8]   INHIBITION OF DNASE ACTIVITY IN PFGE ANALYSIS OF DNA FROM CAMPYLOBACTER-JEJUNI [J].
GIBSON, JR ;
SUTHERLAND, K ;
OWEN, RJ .
LETTERS IN APPLIED MICROBIOLOGY, 1994, 19 (05) :357-358
[9]   Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years [J].
Hoge, CW ;
Gambel, JM ;
Srijan, A ;
Pitarangsi, C ;
Echeverria, P .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (02) :341-345
[10]   ROLE OF THE BETA-LACTAMASE OF CAMPYLOBACTER-JEJUNI IN RESISTANCE TO BETA-LACTAM AGENTS [J].
LACHANCE, N ;
GAUDREAU, C ;
LAMOTHE, F ;
LARIVIERE, LA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (05) :813-818